ProQuest www.csa.com
 
 
RefWorks
  
Discovery Guides Areas
>
>
>
>
>
 
  
e-Journal

 

Anthrax (Bacillus anthracis)
(Released November 2001)

 
  by Roberta A. Gardner  

Review

Key Citations

Web Sites

Glossary

Conferences

Editor
 
Key Citations Short Format Full Format
         
Choose a Category Biological Warfare Toxins Vaccines
  1. Surveillance for Adverse Events Associated with Anthrax Vaccination - U.S. Department of Defense, 1998-2000
    Morbidity and Mortality Weekly Report [Morb. Mortal. Weekly Rep.], vol. 49, no. 16, pp. 341-345, Apr 2000

  2. Current status of immunization against anthrax: old vaccines may be here to stay for a while
    Current Opinion in Infectious Diseases [Curr. Opin. Infect. Dis.], vol. 13, no. 2, pp. 113-120, Apr 2000

  3. Protection against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor Protein
    Infection and Immunity [Infect. Immun.], vol. 69, no. 7, pp. 4509-4515, Jul 2001

  4. Attenuated Nontoxinogenic and Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect against Anthrax
    Infection and Immunity [Infect. Immun.], vol. 68, no. 8, pp. 4549-4558, Aug 2000

  5. Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans
    Vaccine, vol. 19, no. 2-3, pp. 213-216, 15 Sep 2000

  6. Search for Correlates of Protective Immunity Conferred by Anthrax Vaccine
    Infection and Immunity [Infect. Immun.], vol. 69, no. 5, pp. 2888-2893, May 2001

  7. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin
    Vaccine, vol. 19, no. 23-24, pp. 3241-3247, 30 Apr 2001

  8. Characterization of Bacillus anthracis strains used for vaccination
    Journal of Applied Microbiology [J. Appl. Microbiol.], vol. 88, no. 4, pp. 648-654, Apr 2000

  9. Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity
    Proceedings of the National Academy of Sciences, USA [Proc. Natl. Acad. Sci. USA], vol. 97, no. 14, pp. 8027-8032, 5 Jul 2000

  10. Role of Furin in Delivery of a CTL Epitope of an Anthrax Toxin-Fusion Protein
    Microbiology and Immunology [Microbiol. Immunol.], vol. 45, no. 2, pp. 119-125, 2001

  11. The Anthrax Vaccine: A Question of Safety
    Clinical Microbiology Newsletter [Clin. Microbiol. Newsl.], vol. 23, no. 7, pp. 51-54, 1 Apr 2001

  12. Constitutive Expression of Protective Antigen Gene of Bacillus anthracis in Escherichia coli
    Biochemical and Biophysical Research Communications [Biochem. Biophys. Res. Commun.], vol. 283, no. 2, pp. 308-315, 4 May 2001

  13. Delayed Life-Threatening Reaction to Anthrax Vaccine
    Journal of Toxicology: Clinical Toxicology [J. Toxicol.: Clin. Toxicol.], vol. 39, no. 1, pp. 81-84, 2001

  14. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices
    Journal of Toxicology: Clinical Toxicology [J. Toxicol.: Clin. Toxicol.], vol. 39, no. 1, pp. 85-100, 2001

  15. Detection of anthrax vaccine virulence factors by polymerase chain reaction
    Vaccine, vol. 19, no. 30, pp. 4214-4218, 20 Jul 2001